Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-16-009911
Filing Date
2016-01-05
Accepted
2016-01-05 16:35:00
Documents
1
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4123115shreeram_relmada.html 4  
1 OWNERSHIP DOCUMENT f4123115shreeram_relmada.xml 4 3071
  Complete submission text file 0001213900-16-009911.txt   4502
Mailing Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-702-7163
RELMADA THERAPEUTICS, INC. (Issuer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address P.O BOX 2042 PRINCETON NJ 08543
Business Address
Agharkar Shreeram (Reporting) CIK: 0001630639 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55347 | Film No.: 161322752